3Goodman D, Pamer E, Jakubowski A, et al.Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate[J].Clin Infect Dis,2002,35(3):E35-36
4Walsh TJ, Melcher GP, Rinaldi MG,et al. Trichosporon beigelii, an emerging pahogen resistant to amphotericin B[J].J Clin Microbiol,1990,28(7):1616-1622
5Perparim K, Nagai H, Hashimoto A,et al. In vitro susceptibility of Trichosporon beigelii to antifungal agents[J].J Chemother,1996,8(6):445-448
6Anaissie E, Gokaslan A, Hachem R,et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review[J]. Clin Infect Dis,1992,15(5):781-787
7Kamberi P, Atsuro H, Takayoshi T, et al. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice[J]. Chemotherapy,1998,44(1):55-62
8Sasaki E, Tashiro T, Kuroki M,et al. Effects of macrophage colony-stimulating factor (M-CSF) on anti-fungal activity of mononuclear phagocytes against Trichosporon asahii[J].Clin Exp Immunol,2000,119(2):293-298
9Muranaka H, Suga M, Nakagawa K,et al. Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis[J].Infect Immun,1997,65(8):3422-3429
10Yamakami Y, Yamagata E, Karashima R,et al. Recent knowledge allowing diagnosis and treatment of deep-seated trichosporonosis[J]. Nippon Ishinkin Gakkai Zasshi,2000,41(4):235-239
